Professional Documents
Culture Documents
Anemia
Under Supervision
Diagnostic investigations for anemia in children involve analyzing various blood parameters such as
hemoglobin, hematocrit, red blood cell count, and mean corpuscular volume.
Blood Film Analysis
Morphological Classifications Pathophysiological Classifications
Iron is absorbed in the proximal small intestine Common causes of iron deficiency anemia
with the help of duodenal proteins at a rate of include a diet poor in iron, low birth weight,
10% to 20%. Human milk iron is absorbed 3 cow's milk protein allergy, delayed
times more than cow's milk iron. supplementation of cereals beyond 5 months,
and chronic blood loss from various sources.
Clinical Features and Investigations
1 Clinical Features
Pallor, pica, koilonychias, irritability, anorexia, tachycardia, hemic murmurs,
tiredness, glossitis, and CNS features like decreased attention and alertness are
common signs of iron deficiency anemia.
2 Investigations
5. meat
Bloodand fish.
transfusion In severe
anemia-If Hb < 4 gm packed cell 2-
6. 3 ml/kg.
Treat the cause.
Megaloblastic Anemia
Decrease in RBCs synthesis due to defiance of B12 or folic acid.
Causes of Megaloblastic Anemia
B 12
2-decrease absorption (terminal ileum - surgical remove - atrophy due to inflammation as Crops disease)
Folic acid
C-_Luekopenia -infection
3 -Aspiration of BM
4_schilling test
Folic acid should be administered orally stat by 5 mg and higher dose is indicated in hemolysis.
2 Extrinsic Causes
External factors such as infections, autoimmune disorders, and medications trigger the
destruction of red blood cells.
Symptoms and Diagnosis of Hemolytic
Hemolytic Anemia
Symptoms and Diagnostic Tests
The symptoms of hemolytic anemia include pale skin, jaundice, dark-colored urine, and an enlarged
spleen. Diagnostic tests include complete blood count, peripheral smear, and urine tests to identify
hemoglobin breakdown products.
Treatmentand Com plicationsof
Hem olytic Anemia
Treatment Options Possible Complications
Treatment strategies include blood Complications of hemolytic anemia include
transfusions, corticosteroids, gallstones, blood clots, kidney failure, and
immunosuppressive therapy, and heart failure.
splenectomy in severe cases.
Thalassemia
T halassemiaS yndrome
Structure of HB
In genetics : 2pairs of genes are responsible for alpha chains formation , on chromosome 16 .
And 2 pairs of genes are responsible for beta chains formation ,on chromosome 11.
Classification of T halassemiaS yndrome
1_Alpha thalassemia
Is classified according to number of genes deleted : 1_silent carrier state "one gene deletion" 2_alpha
thalassemia trait "two genes deletion" 3_hemoglobin H disease "three genes deletion" 4_hydrops
fetalis "four gene deletion"
2_Beta thalassemia
1_Complete absence of beta chain synthesis or only small amount of beta chain is formed .
Clinical features
2_Hepatosplenomegaly.
3_ Thalassemia facies due to expansion of facial bones because of erythroid hyperplasia (frontal bossing
, prominent maxilla, malocclusion of teeth , depressed nasal bridge)
4_ features of iron overload : _ Growth retardation. _Delayed puberty. _DM. _Cardiac failure due to
cardiomyopathy due to iron overload.
Investigations
1_HB estimation <5% gm.
7_HB electrophoresis : Either fetal HB increased 50_98% or HBA2 increased ,HBA1 decreased.
10_X-ray changes: Hand : rectangular appearance of metacarpals, skull hair on end appearance.
Mild hepatosplenomegaly.
hemolytic anemia.
splenomegaly.
jaundice.
pigment gallstone.
Investigations :
4-Microspherocytes.
Genetic Disorder G6pd disease is a genetic disorder that effects the red blood cells. Enzyme deficiency .
The disease is caused by a deficiency of the enzyme glucose-6-phosphate dehydrogenase,which
responsible for hexose monophos shunt.
Prevalence
G6pd disease is ( x-linked recessive disorder with obvious symptoms)so more common in males.
heterozygous female appear normal, can affect if she is homozygous Inheritance The disease can be
inherited from carrier mothers.
Causes and Risk factors of G6PD
G6pd disease is primarily caused by an inherited mutation in the G6PD gene. This gene provides
instructions for producing an enzyme called glucose-6-phosphate dehydrogenase, which is responsible
for protecting red blood cells from damage caused by certain substances. In addition to the genetic cause
, there are several risk factors that can trigger symptoms in individuals with G6pd deficiency.
1-Certain medications:
such as certain antibiotics, anti malarias, and non steroidal anti inflammatory drugs (NSAIDs)
3- certain infections , particularly bacterial and viral infections , can cause the destruction of red blood
cells in individuals with G6pd deficiency.
4-Certain foods: some foods , such as fava beens, can trigger a reaction in individuals with G6pd
deficiency .
Symptoms and Diagnosis of G6PD
G6pd disease, also known as glucose-6-phosphate dehydrogenase deficiency, is a genetic condition that
affects the red blood cells,It is more common in males and can cause a range of symptoms in pediatric
patients.
1- Sudden Neonatal Jaundice: Yellowing of the skin and eyes ,on set is usually in the first 3 days of life .
2-Sudden pale skin : Reduced red blood cell count can lead to paleness.
3-Dark urine : The breakdown of red blood cells can cause red colored urine.
4-Sudden fever .
Diagnosis of G6pd disease is typically done through a blood test to measure G6PD levels. This test can
determine if a patient has reduced or absent G6pd activity, indicating the presence of the condition.
Complications and ManagementG6PD
1- Anemic HF .
5-Avoiding triggers that can cause hemolytic episodes , such as certain foods or medications .
6-Providing supportive care during hemolytic episodes , such as blood transfusions if necessary.
IVES TIGA TIO N of G6P D
BLOOD DURING ATTACK BLOOD PICTURE;
HEAM-GLI,REA E,ZYME ACTI4ITY ; G6PD E,ZYME LE4EL (2-3 weeks after attack)
Treatment options of G6PD
1- The treatment for pediatric patients with G6pd disease primarily focuses on avoiding tiggers that can
cause a G6PD crisis . This includes certain medications and foods that can lead to the destruction of red
blood cells. In addition to trigger avoidance , supportive care may also be provided to manage symptoms
and complications .
2- Carry a G6pd Deficiency cared to alert health care providers of the condition.
3- Consider genetic testing for family members to identify carriers and potential risks.
Genetic Counseling
1- Provide information on the genetic basis of G6PD deficiency and its potential impact on health.
2- Discuss the risks and benefits of genetic testing for family members.
3- Offer support and resources for families with a history of G6PD deficiency.
Aplastic Anemia
Aplastic anemia is characterized by the failure or
suppression of multipotent myeloid stem cells, resulting
in pancytopenia - a condition characterized by low counts
of red blood cells, white blood cells, and platelets.
Causes of Aplastic Anemia
Idiopathic S econdary causes Hematological Disorders
3 Bleeding T endency
Thrombocytopenia in aplastic anemia can lead to prolonged bleeding and easy bruising.
DifferentialDiagnosisof Aplastic Anemia
1 Idiopathic 2 Leukemia 3 M yeloid M etaplasia
T hrom bocytopen
A type of cancer that A group of rare bone
ic P urpura(IT P)
affects the bone marrow disorders
A condition marrow, leading to marked by abnormal
characterized by low abnormal white blood blood cell production.
platelet levels, leading cell production.
to purpura and
prolonged bleeding.
HematologicalInvestigationsfor
Aplastic Anemia
Common Investigation Tests
Diagnosing aplastic anemia involves a series of hematological tests, including complete blood count
(CBC), peripheral smear, and bone marrow aspiration for detailed cell analysis.
Treatment of Aplastic Anemia
B one M arrow S upportive T herapy Growth Factorsand
Transplantation Im m unotherapy
Blood transfusions,
Transplantation is the antibiotic therapy, and Stimulating factors like G-
preferred treatment method immunosuppressive drugs CSF and erythropoietin,
for aplastic anemia, aiming form a crucial part of along with immunotherapy,
to restore normal bone supportive therapy. play a vital role in managing
marrow function. the disease.
Cases of Anemia
BY : Selwan Mohamed Ebrahim
2- _S erum ferritin ↓↓ _S erum iron ↓↓ _S erum iron binding capacity ↑↑ _P eripheralBlood S mear(P BF)
shows microcytichypochromic,anisocytosis,poikilocytosisand nucleated R B C. _R ed celldistribution
width(R D W ) ↑↑ _R eticulocytesnormalorincreased _T hrom bocytosissometimesand Bone marrow
hypercellular
2-Differential Diagnosis?
c-A ncylostomiasis
a-Folate
b-Vitamin C
c-Calcium
d- Iron
b-R eticulocytosis
e-Raised HbF
thalassemia major?
a-Diabetesmellites
b-Renal failure
c-Heartfailure
d-Intestinal obstruction
e-Cirrhosis
MCQ 3
5.Allthefollowing are com m only observedinaplasticanemiaexcept:
b-S plenomegaly
d-R ecurrentInfections
a)110ml/kg
b)20mlCkg
c)85ml/kg
d)60mlCkg
MCQ 4
7-T he deficiencyanemiaism ostlikely to be caused by:
a) Parasitic infection.
b) Hematuria
c) Artificial feeding.
d)Allofftheabove.
a)M alaria.
b)SLE
c)Iron deficiencyanemia.
d)DIC.
MCQ 5
9-Iron deficiency anemia is characterized by the following except:
a)M icrocytichypochromicanemia.
c)Decreasedserum ferritin.
d)pica
b)zinc deficiency.
c)copper deficiency.
d)B_thalassemia.
MCQ 6
11-W hich ofthefollowingisnot true about megaloblasticanemia:
a)A utosomaldominantininheritance.
b) splenectomy.
a)microcytosis.
b)Acanthocytosis.
c)hypochromia.
d) increased reticulocyte.
a)bony hyperplasia.
b)A uto-splenectom y.
c) mongoloid features.
d)marked hepatosplenomegaly.
MCQ End
15-A plasticanemiacan besecondary to:
a) Radiation.
b) hepatitisA.
c) parvovirus B-19.
d)Allofftheabove.
Answers of MCQ
1 .bone marrow infiltration
2. calcium
4. Heart failure
5. S plenomegaly
6. 85ml/kg
7. Alloftheabove
13. Acanthocytosis
14. Auto-splenectomy
15. Alloftheabove